Vitamin D for the treatment of chronic painful conditions in adults

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 5, 2015, Pages

  Straube, Sebastian ^a   Derry, Sheena ^b   Straube, Carmen ^c   Moore, R Andrew ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN D; ALFACALCIDOL; HYDROXYCOLECALCIFEROL; VITAMIN;

ANALGESIA; CHRONIC PAIN; DRUG EFFICACY; DRUG SAFETY; FIBROMYALGIA; HUMAN; KNEE OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN INTENSITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; ADULT; ARTHRITIS, RHEUMATOID; COMPLICATION; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, KNEE; POLYMYALGIA RHEUMATICA; RANDOMIZED CONTROLLED TRIAL (TOPIC); VITAMIN D DEFICIENCY;

ADULT; ARTHRITIS, RHEUMATOID; CHRONIC PAIN; ERGOCALCIFEROLS; HUMANS; HYDROXYCHOLECALCIFEROLS; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS, KNEE; POLYMYALGIA RHEUMATICA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84945322992     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007771.pub3     Document Type: Review

References (95)

1. Brohult J, Jonson B. Effects of large doses of calciferol on patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 1973;2(4):173-6.
2. Di Munno O, Beghe F, Favini P, Di Giuseppe P, Pontrandolfo A, Occhipinti G, et al. Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium. Clinical Rheumatology 1989;8(2):202-7.
3. Hansen KE, Bartels CM, Gangnon RE, Jones AN, Gogineni J. An evaluation of high-dose vitamin D for rheumatoid arthritis. Journal of Clinical Rheumatology 2014;20(2):112-4. [DOI: 10.1097/RHU.0000000000000072]
4. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013;309(2):155-62. [DOI: 10.1001/jama.2012.164487]
5. Salesi M, Farajzadegan Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatology International 2012;32(7):2129-33. [DOI: 10.1007/s00296-011-1944-5]
6. Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S, et al. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clinical Orthopaedics and Related Research 2013;471(11):3556-62. [DOI: 10.1007/s11999-013-3201-6]
7. Schreuder F, Bernsen RM, van der Wouden JC. Vitamin D supplementation for nonspecific musculoskeletal pain in non-Western immigrants: a randomized controlled trial. Annals of Family Medicine 2012;10(6):547-55. [DOI: 10.1370/afm.1402]
8. Warner AE, Arnspiger SA. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases 2008;14(1):12-6. [DOI: 10.1097/RHU.0b013c31816356a9]
9. Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain 2014;155(2):261-8. [DOI: 10.1016/j.pain.2013.10.002]
10. Yamauchi Y, Tsunematsu T, Konda S, Hoshino T, Itokawa Y, Hoshizaki H. A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA). Ryumachi. [Rheumatism] 1989;29(1):11-24.
11. Abou-Raya S, Abou-Raya A, Helmii M. Efficacy of vitamin D supplementation in the treatment of fibromyalgia: randomized controlled trial. Annals of the Rheumatic Diseases 2014;73:295. [DOI: 10.1136/annrheumdis-2014-eular.2767]
12. Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, et al. Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis and Rheumatism 2006;55(4):610-5. [DOI: 10.1002/art.22088]
13. Arden NK, Cro S, Dore C, Cooper C, O'Neil T, Birrell F, et al. Effect of vitamin D supplementation on radiographic knee osteoarthritis. Osteoarthritis and Cartilage 2014;22:S375. [DOI: 10.1016/j.joca.2014.02.699]
14. Björkman M, Sorva A, Tilvis R. Vitamin D supplementation has no major effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. Aging Clinical and Experimental Research 2008;20(4):316-21.
15. Chlebowski RT, Pettinger M, Johnson KC, Wallace R, Womack C, Mossavar-Rahmani Y, et al. Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial. Journal of the Academy of Nutrition and Dietetics 2013;113(10):1302-10. [DOI: 10.1016/j.jand.2013.06.007]
16. de Nijs RN, Jacobs JW, Lems WF, Laan RF, Algra A, Huisman AM, et al. STOP Investigators. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. New England Journal of Medicine 2006;355(7):675-84. [CTG: NCT00138983]
17. Ding C, Cicuttini F, Jones G. Vitamin D supplementation in patients with osteoarthritis. JAMA 2013;309(15):1583. [DOI: 10.1001/jama.2013.3775]
18. Dottori L, D'Ottavio D, Brundisini B. Calcifediol and calcitonin in the therapy of rheumatoid arthritis. A short-term controlled study [Calcifediolo e calcitonina nella terapia dell'artrite reumatoide. Studio controllato a breve termine]. Minerva Medica 1982;73(43):3033-40.
19. Felson DT. CORR insights: does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clinical Orthopaedics and Related Research 2013;471(11):3563-4. [DOI: 10.1007/s11999-013-3269-z]
20. Gendelman O, Itzhaki D, Amital H. A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Annals of the Rheumatic Diseases 2014:1090. [DOI: 10.1136/annrheumdis-2014-eular.2555]
21. Grove O, Halver B. Relief of osteoporotic backache with fluoride, calcium, and calciferol. Acta Medica Scandinavica 1981;209(6):469-71.
22. Kessenich CR. Vitamin D deficiency and leg pain in the elderly. Nurse Practitioner 2010;35(3):12-3. [DOI: 10.1097/01.NPR.0000368901.92828.17]
23. Knutsen KV, Madar AA, Brekke M, Meyer HE, Natvig B, Mdala I, et al. Effect of vitamin D on musculoskeletal pain and headache: A randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway. Pain 2014;155(12):2591-8. [DOI: 10.1016/j.pain.2014.09.024]
24. Kragstrup TW. Vitamin D supplementation for patients with chronic pain. Scandinavian Journal of Primary Health Care 2011;29(1):4-5. [DOI: 10.3109/02813432.2010.530738]
25. Krocker D, Ullrich H, Buttgereit F, Perka C. Influence of adjuvant pain medication on quality of life in the treatment of postmenopausal osteoporosis [Einfluss der adjuvanten Schmerztherapie in der Behandlung der postmenopausalen Osteoporose auf die Lebensqualität]. Der Orthopäde 2008;37(5):435-9. [DOI: 10.1007/s00132-008-1259-8]
26. Lyritis GP, Androulakis C, Magiasis B, Charalambaki Z, Tsakalakos N. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial. Bone and Mineral 1994;27(3):209-17.
27. Mascitelli L, Goldstein MR, Grant WB. Hypovitaminosis D and pain in cystic fibrosis. Pain Medicine 2012;13(5):735-6. [DOI: 10.1111/j.1526-4637.2012.01372.x]
28. McAlindon TE, Dawson-Hughes B, Driban J, LaValley M, Lee JY, Lo GH, et al. Clinical trial of vitamin D to reduce pain and structural progression of knee osteoarthritis (OA). Arthritis and Rheumatism 2010;62(Suppl 10):706. [DOI: 10.1002/art.28474]
29. Osunkwo I, Ziegler T, Alvarez J, George J, Cherry K, Rhodes J, et al. A randomized double blind, placebo controlled study of vitamin D to ameliorate sickle cell chronic pain. Journal of Pain 2012;13(4):S73. [DOI: 10.1016/j.jpain.2012.01.302]
30. Osunkwo I, Ziegler T, Cherry K, Alvarez J, Ghosh S, Rhodes J, et al. Results of a randomized double blind placebo controlled trial of vitamin D to ameliorate sickle cell chronic pain. American Journal of Hematology 2012;87(7):E56-7.
31. Osunkwo I, Ziegler TR, Alvarez J, McCracken C, Cherry K, Osunkwo CE, et al. High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study. British Journal of Haematology 2012;159(2):211-5. [DOI: 10.1111/bjh.12019.]
32. Ringe JD, Cöster A, Meng T, Schacht E, Umbach R. Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium [Therapie der Glucocorticoid-induzierten Osteoporose mit Alfacalcidol/Kalzium und Vitamin D/Kalzium]. Zeitschrift für Rheumatologie 2000;59(3):176-82.
33. Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatology International 2004;24(2):63-70. [DOI: 10.1007/s00296-003-0361-9]
34. Ringe JD, Faber H, Fahramand P, Schacht E. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. Journal of Rheumatology Supplement 2005;76:33-40.
35. Ringe JD, Farahmand P, Schacht E, Rozehnal A. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial). Rheumatology International 2007;27(5):425-34. [DOI: 10.1007/s00296-006-0288-z]
36. Sakalli H, Arslan D, Yucel AE. The effect of oral and parenteral vitamin D supplementation in the elderly: a prospective, double-blinded, randomized, placebo-controlled study. Rheumatology International 2012;32(8):2279-83. [DOI: 10.1007/s00296-011-1943-6]
37. Sanghi D, Srivastava RN, Agarwal S, Natu SM, Singh A, Avasthi S. Role of vitamin D in osteoarthritis knee: a six month double blind, randomized, placebo control trial. Osteoarthritis and Cartilage 2011;19(S1):S36.
38. Sanghi D, Srivastava RN. Role of vitamin D in osteoarthritis knee: a six month double blind, randomized, placebo control trial. Annals of the Rheumatic Disease 2012;71(Suppl 3):416.
39. Sanghi D, Srivastava RN, Mishra A, Natu S, Mishra R, Agarwal S. Role of vitamin D in osteoarthritis knee: a six month double blind, randomized, placebo control trial. Osteoarthritis and Cartilage 2013;21:S28-9.
40. Sanghi D, Srivastava RN, Raj S, Mishra A, Natu SM, Agarwal S. Vitamin D receptor gene polymorphisms modulate the clinico-radiological response to vitamin D supplementation in knee osteoarthritis. Osteoarthritis and Cartilage 2014;22:S235-6.
41. Wicherts IS, Boeke AJ, van der Meer IM, van Schoor NM, Knol DL, Lips P. Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial. Osteoporosis International 2011;22(3):873-82. [DOI: 10.1007/s00198-010-1343-x]
42. Wynn RL. Vitamin D deficiency and nonspecific musculoskeletal pain. General Dentistry 2013;61(3):10-3.
43. ACTRN12610000322033 Vitamin D as an analgesic for neuropathic pain in type 2 diabetes. anzctr.org.au/Trial/Registration/TrialReview.aspx?id=335359 (accessed 2 March 2015).
44. Cao Y, Jones G, Cicuttini F, Winzenberg T, Wluka A, Sharman J, et al. Vitamin D supplementation in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials 2012;13:131. [CTG: NCT01176344; DOI: ACTRN12610000495022]
45. CTRI/2014/06/004658 Effect of vitamin D on progression of primary osteoarthritis knee - a double blind randomized control trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=CTRI/2014/06/004658 (accessed 2 March 2015).
46. EUCTR2009-015835-34-IT Vitamin D effect on T lymphocytes and osteoclastogenesis in rheumatoid arthritis. apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2009-015835-34-IT (accessed 2 March 2015).
47. EUCTR 2014-000047-33/NL. The effect of high-resistance muscle strength training and vitamin D supplementation in persons with knee osteoarthritis - vitD-EX. www.clinicaltrialsregister.eu/ctr-search/trial/2014-000047-33/NL (accessed 2 March 2015).
48. ISRCTN94818153 A randomised, double-blind, placebo-controlled trial of vitamin D supplementation in the management of symptomatic knee osteoarthritis (the VIDEO study). isrctn.com/ISRCTN94818153 (accessed 2 March 2015).
49. NCT00279461 Vitamin D deficiency causes immune dysfunction and enables or perpetuates the development of rheumatoid arthritis. clinicaltrials.gov/ct2/show/NCT00279461?term=NCT00279461&rank=1 (accessed 2 March 2015).
50. Vitamin D treatment to patients suffering from chronic pain and vitamin D hypovitaminosis. clinicaltrials.gov/ct2/show/NCT01023490?term=NCT01023490&rank=1 (accessed 2 March 2015).
51. NCT01351805 Vitamin D and fish oil for autoimmune disease, inflammation and knee pain. clinicaltrials.gov/ct2/show/NCT01351805?term=NCT01351805&rank=1 (accessed 2 March 2015).
52. NCT01426347 Treatment of vitamin D deficiency in patients with rheumatoid arthritis. clinicaltrials.gov/ct2/show/NCT01426347?term=NCT01426347&rank=1 (accessed 2 March 2015).
53. NCT02002000 Chronic pain and vitamin D. clinicaltrials.gov/ct2/show/NCT02002000?term=NCT02002000&rank=1 (accessed 2 March 2015).
54. NCT02243800 Study of the efficacy and safety of cholecalciferol supplementation on the activity of rheumatoid arthritis in patients with vitamin D deficiency (SCORPION). clinicaltrials.gov/ct2/show/NCT02243800?term=NCT02243800&rank=1 (accessed 2 March 1915).
55. Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research 2004;13(2):283-98.
56. Atherton K, Berry DJ, Parsons T, Macfarlane GJ, Power C, Hypponen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Annals of the Rheumatic Diseases 2009;68(6):817-22. [DOI: 10.1136/ard.2008.090456]
57. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2007;167:1730-7.
58. Bannwarth B, Blotman F, Roué-Le Lay K, Caubère JP, André E, Taïeb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009;76(2):184-7.
59. Bennett M, Heard R. Treatment of multiple sclerosis with hyperbaric oxygen therapy. Undersea and Hyperbaric Medicine 2001;28(3):117-22.
60. Benson J, Wilson A, Stocks N, Moulding N. Muscle pain as an indicator of vitamin D deficiency in an urban Australian Aboriginal population. Medical Journal of Australia 2006;185:76-7.
61. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD007470.pub3]
62. Carroll D, Tramèr M, McQuay H, Nye B, Moore A. Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain. British Journal of Anaesthesia 1996;77(6):798-803.
63. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
64. Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ 2013;346:f2304. [DOI: 10.1136/bmj.f2304]
65. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21. [DOI: 10.1016/j.jpain.2007.09.005]
66. Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: update 2013: from rickets prophylaxis to general preventive healthcare. Dermato-Endocrinology 2013;5(3):331-47. [DOI: 10.4161/derm.26738]
67. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
68. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007;357:266-81.
69. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011;96(7):1911-30. [DOI: 10.1210/jc.2011-0385.]
70. Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clinic Proceedings 2013;88(7):720-55. [DOI: 10.1016/j.mayocp.2013.05.011]
71. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.
72. Jadad AR, Carroll D, Moore A, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2-3):239-46. [DOI: 10.1016/0304-3959(96)03033-3]
73. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12. [DOI: 10.1016/0197-2456(95)00134-4]
74. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
75. Lotfi A, Abdel-Nasser AM, Hamdy A, Omran AA, El-Rehany MA. Hypovitaminosis D in female patients with chronic low back pain. Clinical Rheumatology 2007;26:1895-901. [DOI: 10.1007/s10067-007-0603-4]
76. Mas AJ, Carmona L, Valverde M, Ribas B, EPISER Study Group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clinical and Experimental Rheumatology 2008;26(4):519-26.
77. McQuay H, Carroll D, Moore A. Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems. Pain 1996;64(2):331-5. [DOI: 10.1016/0304-3959(95)00116-6]
78. McQuay HJ, Smith LA, Moore RA. Chronic pain. In: Stevens A, Raferty J, Mant J, Simpson S editor(s). Health Care Needs Assessment. Oxford: Radcliffe Publishing Ltd, 2007:519-600. [ISBN: 978-1-84619-063-6]
79. Mitsikostas DD, Tsaklakidou D, Athanasiadis N, Thomas A. The prevalence of headache in Greece: correlations to latitude and climatological factors. Headache 1996;36:168-73.
80. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
81. Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0-19-856604-2]
82. Moore RA, Moore OA, Derry S, McQuay HJ. Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores. Arthritis Research and Therapy 2008;10(2):R39. [DOI: 10.1186/ar2394]
83. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. ACTINPAIN Writing Group of the IASP Special Interest Group on Systematic Reviews in Pain Relief, Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors. "Evidence" in chronic pain - establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. [DOI: 10.1016/j.pain.2010.05.011]
84. Moore RA, Straube S, Aldington D. Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome. Anaesthesia 2013;68(4):400-12. [DOI: 10.1111/anae.12148]
85. Moore AR, Derry S, Taylor RS, Straube S, Phillips CJ. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice 2014;14(1):79-94. [DOI: 10.1111/papr.12050.]
86. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics with Confidence - Confidence Intervals and Statistical Guidelines. London: British Medical Journal, 1995:50-63.
87. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515. [DOI: 10.1136/bmj.c3515]
88. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery: a review of predictive factors. Anesthesiology 2000;93:1123-33.
89. Saastamoinen P, Laaksonen M, Lahelma E, Leino-Arjas P. The effect of pain on sickness absence among middle-aged municipal employees. Journal of Occupational and Environmental Medicine 2009;66(2):131-6. [DOI: 10.1136/oem.2008.040733]
90. Saps M, Blank C, Khan S, Seshadri R, Marshall B, Bass L, et al. Seasonal variation in the presentation of abdominal pain. Journal of Pediatric Gastroenterology and Nutrition 2008;46:279-84. [DOI: 10.1097/MPG.0b013e3181559bd3]
91. Verhaak PF, Kerssens JJ, Dekker J, Sorbi MJ, Bensing JM. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain 1998;77(3):231-9. [DOI: 10.1016/S0304-3959(98)00117-1]
92. Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care and Research 2013;65(5):786-92. [DOI: 10.1002/acr.21896.]
93. Zeng QY, Chen R, Xiao ZY, Huang SB, Liu Y, Xu JC, et al. Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study. Journal of Rheumatology 2004;31:2439-43.
94. Straube S, Moore RA, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain 2009;141(1-2):10-3. [DOI: 10.1016/j.pain.2008.11.010]
95. Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007771.pub2]